Loading
Surgeon who developed the laparoscopic score for predicting whether ovarian cancer can be fully removed.
Anna Fagotti is Director of the Gynecologic Oncology Unit at Policlinico Universitario A. Gemelli in Rome and Professor at the Università Cattolica. Her specialisms are ovarian cancer surgery, laparoscopic assessment and cytoreductive surgery. She devised the Fagotti laparoscopic predictive index, a score used to judge whether advanced ovarian cancer can be completely removed at surgery. Her papers include the SCORPION randomised trial of primary debulking surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer, the INTERNATIONAL MISSION study of minimally invasive surgery after neoadjuvant chemotherapy, and the ESGO-ESMO-ESP consensus recommendations on ovarian cancer. Her publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) | International Journal of Gynecological Cancer | 2020 |
| The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy | International Journal of Gynecological Cancer | 2019 |
| ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease | Annals of Oncology | 2024 |
Shares International journal of gynecological cancer, European Society of Gynaecological Oncology, Ovarian cancer.
Shares Policlinico Universitario A. Gemelli, International journal of gynecological cancer, European Society of Gynaecological Oncology, Ovarian cancer.
Shares European Society of Gynaecological Oncology, Ovarian cancer.
Shares International journal of gynecological cancer, Ovarian cancer.
Shares International journal of gynecological cancer, Ovarian cancer.
Shares European Society of Gynaecological Oncology, Ovarian cancer.
Shares Policlinico Universitario A. Gemelli, Ovarian cancer.
Shares European Society of Gynaecological Oncology, Ovarian cancer.